Pixium Vision
Pixium Vision SA's assets, including the PRIMA retinal implant system, have been acquired by Science Corporation. The company focuses on clinical trials for patients with late-stage macular degeneration. Its European clinical operations and manufacturing are now managed through La Science SAS.
Healthtech
Medical Devices
Biotechnology
Funding summary
- Total raised
- €25.6M
- Funding rounds
- 2
Investors in Pixium Vision
Investors on record for Pixium Vision. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Pixium Vision?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors